Cambridge Molecular ^Companies

Cambridge Molecular is a biotechnology company that specializes in accelerating drug discovery through the use of novel algorithms and cloud computing. Their main goal is to reduce the time and risk involved in the drug discovery process. They offer a suite of DEL data-powered virtual screening systems, including the DeepDELve 2 tool for deep learning DEL follow-up. Additionally, they have developed the PocketMapper system for automated extraction of chemical property information from scientific documents. Their achievements include achieving a remarkable 40% hit-rate from a commercial library using their virtual screening tools, enabling exploration beyond traditional DEL-like spaces.